Drugs / Boca HBVIg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01421212 | Nov 1999 → Feb 2002 | hepatitis B virus infection | Biotest Pharmaceuticals Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Boca HBVIg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01421212 ↗ |
| Modality | Protein / enzyme biologic | “Hepatitis B Immune Globulin (Boca HBVIg)” NCT01421212 ↗ |
| Route | Intravenous | “Intravenous Boca HBVIg 10,000 IU administered intraoperatively” NCT01421212 ↗ |